Parathyroid hormone levels following denosumab vs. zoledronic acid therapy for osteoporosis
Bone · 2025
DOI: 10.1016/j.bone.2025.117407 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Bone, 2025. Verfasst von Pnina Rotman-Pikielny und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Endocrinology, Diabetes and Metabolism, Meir Medical Center, Kfar Saba, Israel; Faculty of Medical & Health Sciences, Tel Aviv Universit…. Hauptthemen laut MEDLINE: Parathyroid Hormone, Denosumab, Osteoporosis, Imidazoles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Endocrinology, Diabetes and Metabolism, Meir Medical Center, Kfar Saba, Israel; Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel. Electronic address: pnina.rotman@clalit.org.il.
- Institute of Endocrinology, Diabetes and Metabolism, Meir Medical Center, Kfar Saba, Israel.
- Institute of Endocrinology, Diabetes and Metabolism, Meir Medical Center, Kfar Saba, Israel; Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel.
- Research Institute, Meir Medical Center, Kfar Saba, Israel.
Zitieren
APA
Rotman-Pikielny, P., Barzilai-Yosef, L., Ramaty, E., Braginski-Shapira, S., Meron, M. K., & Lurie, T. H. (2025). Parathyroid hormone levels following denosumab vs. zoledronic acid therapy for osteoporosis. Bone. https://doi.org/10.1016/j.bone.2025.117407
Vancouver
Rotman-Pikielny P, Barzilai-Yosef L, Ramaty E, Braginski-Shapira S, Meron MK, Lurie TH. Parathyroid hormone levels following denosumab vs. zoledronic acid therapy for osteoporosis. Bone. 2025. doi:10.1016/j.bone.2025.117407
BibTeX
@article{RotmanPikielny2025,
author = {Rotman-Pikielny, Pnina and Barzilai-Yosef, Liat and Ramaty, Erez and Braginski-Shapira, Sofia and Meron, Michal Kasher and Lurie, Tzipi Hornik},
title = {Parathyroid hormone levels following denosumab vs. zoledronic acid therapy for osteoporosis},
journal = {Bone},
year = {2025},
doi = {10.1016/j.bone.2025.117407}
}
EUVIMED